Adenomyomatous Polyp of the Uterus in a Patient Receiving Tamoxifen

Japanese Journal of Clinical Oncology

Volumn 27, Issue 5, 1997, Pages 350-352

  Nasu, Kaei ^a   Arima, Kazuyo ^a   Yoshimatsu, Jun ^a   Miyakawa, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adenomyomatous polyp; Breast cancer; Tamoxifen

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR; TAMOXIFEN;

ADENOMATOUS POLYP; ARTICLE; BREAST TUMOR; CASE REPORT; CHEMISTRY; ECHOGRAPHY; FEMALE; HUMAN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PELVIS; UTERUS CANCER;

ADENOMATOUS POLYPS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PELVIS; RECEPTORS, ESTROGEN; TAMOXIFEN; UTERINE NEOPLASMS;

EID: 0031253182     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.5.350     Document Type: Article

References (19)

1. Pasqualini JR, Sumida C, Giambiagi N. Pharmacodynamic and biological effects of anti-estrogens in different models. J Steroid Biochem 1988;31:613-43.
2. Fisher B, Constantino J, Remond C, Poisson R, Bowman D, Couture J, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors N Engl J Med 1989;320:479-84.
3. Seoud MA-F, Johnson J, Weed JC Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993;82:165-9.
4. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Latikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-4.
5. Corley D, Rowe J, Curtis MT, Hogan WM, Noumoff JS, Lwolsi VA. Postmenopausal bleeding from unusual endometnal polyps in women on chronic tamoxifen therapy. Obstet Gynecol 1992;79:111-6.
6. Uziely B, Lewin A, Brufman G, Dorembus D, Mor-Yosef S. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993;26:101-5.
7. Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer, sonographic and pathologic correlation. Am J Roentgenol 1993;160:809-12.
8. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 1994;343:1318-21
9. Cohen I, Beyth Y, Tepper R, Figer A, Shapira J, Cordoba M, et al. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity? Gynecol Oncol 1995;58:86-91.
10. Dilts PV, Hopkins MP, Chang AE, Cody RL. Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol 1992;166:167-8.
11. Leo L, Lanza A, Re A, Tessarolo M, Bellino R, Lauricella A, et al. Leiomyomas in patients receiving Tamoxifen. Clin Exp Obstet Gynecol 1994;21:94-8.
12. Barbieri RL, Ferracci AL, Droesch JN, Rochelson BL. Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer. Fertil Steril 1993;59:459-60.
13. Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol 1996;174:141-4
14. Nasu K, Sugano T, Miyakawa I. Adenomyomatous polyp of the uterus. Int J Gynecol Obstet 1995;48:319-21.
15. Baum M. Controlled trial of tamoxifen as single adjuvant agent in the management of early breast cancer: analysis at six years by Nolvadex Adjuvant Trial Organization. Cancer 1985;1:836-9
16. Boccardo F, Buzzi L, Rubagotti A, Nicolo O, Rosso R. Oestrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981;38:281-8.
17. Gorodeski GI, Beery R, Lunenfeld B, Geter A. Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal premenopausal and postmenopausal endometrium. Fertil Steril 1992;57:320-7.
18. Peterson WF, Novak ER. Endometrial polyps. Obstet Gynecol 1956;8:40.
19. Hertig AT, Gore H. Tumors of the Female Sex Organs. Part 2-Supplement. Tumors of the Vulva, Vagina and Uterus. Atlas of Tumor Pathology. Washington DC Armed Forces Institute of Pathology, 1968;322.